|
Volumn 174, Issue FEB. SUPPL. 37, 1999, Pages 41-44
|
Olanzapine: Preclinical pharmacology and recent findings
|
Author keywords
[No Author keywords available]
|
Indexed keywords
OLANZAPINE;
AMINO ACID RECEPTOR BLOCKING AGENT;
BENZODIAZEPINE DERIVATIVE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLOZAPINE;
DRUG DERIVATIVE;
DRUG VEHICLE;
MUSCARINIC RECEPTOR BLOCKING AGENT;
NEUROLEPTIC AGENT;
PHENCYCLIDINE;
PIRENZEPINE;
SCOPOLAMINE;
ANIMAL EXPERIMENT;
COGNITION;
DRUG RECEPTOR BINDING;
EXTRAPYRAMIDAL SYMPTOM;
MAZE TEST;
NONHUMAN;
PSYCHOPHARMACOTHERAPY;
RECEPTOR AFFINITY;
REVIEW;
SCHIZOPHRENIA;
TASK PERFORMANCE;
ANIMAL;
ANIMAL BEHAVIOR;
DRUG EFFECT;
DRUG SCREENING;
HUMAN;
MOTOR ACTIVITY;
SOCIAL ISOLATION;
VEHICLES;
ANIMALS;
ANTIPSYCHOTIC AGENTS;
BEHAVIOR, ANIMAL;
BENZODIAZEPINES;
CHOLINERGIC ANTAGONISTS;
CLOZAPINE;
DRUG EVALUATION, PRECLINICAL;
EXCITATORY AMINO ACID ANTAGONISTS;
HUMANS;
MAZE LEARNING;
MOTOR ACTIVITY;
MUSCARINIC ANTAGONISTS;
PHENCYCLIDINE;
PIRENZEPINE;
SCHIZOPHRENIA;
SCOPOLAMINE;
SOCIAL ISOLATION;
VEHICLES;
|
EID: 0033032822
PISSN: 00071250
EISSN: None
Source Type: Journal
DOI: 10.1192/s0007125000293665 Document Type: Review |
Times cited : (14)
|
References (10)
|